- Home
- PCVX vs TMDX Comparison
PCVX vs TMDX Comparison
Compare PCVX & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- TMDX
- Stock Information
- Founded
- PCVX 2013
- TMDX 1998
- Country
- PCVX United States
- TMDX United States
- Employees
- PCVX N/A
- TMDX N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PCVX Health Care
- TMDX Health Care
- Exchange
- PCVX Nasdaq
- TMDX Nasdaq
- Market Cap
- PCVX 4.4B
- TMDX 4.8B
- IPO Year
- PCVX 2020
- TMDX 2019
- Fundamental
- Price
- PCVX $32.70
- TMDX $127.55
- Analyst Decision
- PCVX Strong Buy
- TMDX Buy
- Analyst Count
- PCVX 10
- TMDX 9
- Target Price
- PCVX $136.50
- TMDX $123.00
- AVG Volume (30 Days)
- PCVX 1.3M
- TMDX 1.4M
- Earning Date
- PCVX 08-06-2025
- TMDX 07-30-2025
- Dividend Yield
- PCVX N/A
- TMDX N/A
- EPS Growth
- PCVX N/A
- TMDX 2163.11
- EPS
- PCVX N/A
- TMDX 2.02
- Revenue
- PCVX N/A
- TMDX $531,292,000.00
- Revenue This Year
- PCVX N/A
- TMDX $34.57
- Revenue Next Year
- PCVX N/A
- TMDX $20.83
- P/E Ratio
- PCVX N/A
- TMDX $63.21
- Revenue Growth
- PCVX N/A
- TMDX 48.09
- 52 Week Low
- PCVX $27.66
- TMDX $55.00
- 52 Week High
- PCVX $121.06
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- PCVX 47.81
- TMDX 56.67
- Support Level
- PCVX $29.08
- TMDX $114.30
- Resistance Level
- PCVX $34.50
- TMDX $133.54
- Average True Range (ATR)
- PCVX 1.38
- TMDX 6.54
- MACD
- PCVX -0.18
- TMDX 1.99
- Stochastic Oscillator
- PCVX 48.69
- TMDX 79.22
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.